Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Perfect

Showing results (261-270 of 328) with videos related to

Pageof 33
Sort By:
Antimicrobial Agents and Chemotherapy|June 13, 2018
<i>In Vitro</i> and <i>In Vivo</i> Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against CryptococcusKaren Joy Shaw, Wiley A Schell, Jonathan Covel, et al.
Eukaryotic Cell|July 13, 2006
Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatusWilliam J Steinbach, Robert A Cramer, B Zachary Perfect, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2003
Voriconazole treatment for less-common, emerging, or refractory fungal infectionsJohn R Perfect, Kieren A Marr, Thomas J Walsh, et al.
The American Journal of Pathology|August 1, 2012
Virulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain disseminationXiumiao He, Daniel M Lyons, Dena L Toffaletti, et al.
The Journal of Infectious Diseases|April 20, 2013
Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patientsLucy O'Connor, Joanne Livermore, Andrew D Sharp, et al.
Mbio|August 25, 2025
Inhibitors of trehalose-6-phosphate synthase activity in fungal pathogens compromise thermal tolerance pathwaysYi Miao, Vikas Yadav, William Shadrick, et al.
Plos Genetics|June 21, 2008
Plasminogen alleles influence susceptibility to invasive aspergillosisAimee K Zaas, Guochun Liao, Jason W Chien, et al.
ASM Case Reports|March 19, 2026
Multisystem <i>Lomentospora prolificans</i> progression on fosmanogepix despite <i>in vitro</i> activity: a call for expanding clinical research on novel antifungalsRyan A Cooper, Sana Arif, Arthur W Baker, et al.
Eukaryotic Cell|June 8, 2006
Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin productionRobert A Cramer, Michael P Gamcsik, Rhea M Brooking, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2023
Pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitisCharles D Giamberardino, Jennifer L Tenor, Dena L Toffaletti, et al.
Pageof 33

Showing results (261-270 of 328) with videos related to

Sort By:
Pageof 33
Antimicrobial Agents and Chemotherapy|June 13, 2018
<i>In Vitro</i> and <i>In Vivo</i> Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against CryptococcusKaren Joy Shaw, Wiley A Schell, Jonathan Covel, et al.
Eukaryotic Cell|July 13, 2006
Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatusWilliam J Steinbach, Robert A Cramer, B Zachary Perfect, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2003
Voriconazole treatment for less-common, emerging, or refractory fungal infectionsJohn R Perfect, Kieren A Marr, Thomas J Walsh, et al.
The American Journal of Pathology|August 1, 2012
Virulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain disseminationXiumiao He, Daniel M Lyons, Dena L Toffaletti, et al.
The Journal of Infectious Diseases|April 20, 2013
Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patientsLucy O'Connor, Joanne Livermore, Andrew D Sharp, et al.
Mbio|August 25, 2025
Inhibitors of trehalose-6-phosphate synthase activity in fungal pathogens compromise thermal tolerance pathwaysYi Miao, Vikas Yadav, William Shadrick, et al.
Plos Genetics|June 21, 2008
Plasminogen alleles influence susceptibility to invasive aspergillosisAimee K Zaas, Guochun Liao, Jason W Chien, et al.
ASM Case Reports|March 19, 2026
Multisystem <i>Lomentospora prolificans</i> progression on fosmanogepix despite <i>in vitro</i> activity: a call for expanding clinical research on novel antifungalsRyan A Cooper, Sana Arif, Arthur W Baker, et al.
Eukaryotic Cell|June 8, 2006
Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin productionRobert A Cramer, Michael P Gamcsik, Rhea M Brooking, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2023
Pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitisCharles D Giamberardino, Jennifer L Tenor, Dena L Toffaletti, et al.
Pageof 33